US Stock MarketDetailed Quotes
AMIX Autonomix Medical
- 6.280
- -7.240-53.55%
Close Nov 22 16:00 ET
- 6.450
- +0.170+2.71%
Post 20:02 ET
7.24MMarket Cap-515P/E (TTM)
6.660High5.850Low945.99KVolume6.200Open13.520Pre Close6.21MTurnover145.78%Turnover RatioLossP/E (Static)1.15MShares152.00052wk High2.39P/B4.08MFloat Cap5.85052wk Low--Dividend TTM648.91KShs Float152.000Historical High--Div YieldTTM5.99%Amplitude5.850Historical Low6.562Avg Price1Lot Size
About Autonomix Medical Company
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in Doylestown, PA.
Company Profile
SymbolAMIX
Company NameAutonomix Medical
Listing DateJan 29, 2024
Issue Price5.00
CEOMr. Bradley Hauser
MarketNASDAQ
Employees8
Fiscal Year Ends03-31
Address21 Waterway Avenue,Suite 300
CityThe Woodlands
ProvinceTexas
CountryUnited States of America
Zip Code77380
Phone1-713-588-6150
Websitehttp://autonomix.com
Company Executives
- Name
- Position
- Salary
- Bradley Hauser
- President and Chief Executive Officer
- --
- Trent Smith
- Chief Financial Officer and Principal Accounting Officer
- 1.14M
- Landy Toth
- Chief Technology Officer
- 352.74K
- Dr. Robert Schwartz
- Chief Medical Officer
- 382.86K
- Walter V. Klemp
- Executive Chairman of the Board
- 365.24K
- Lori Bisson
- Executive Vice Chairman of the Board
- 2.22M
- Jonathan P. Foster
- Independent Director
- 50.00K
- David Andrew Robins
- Independent Director
- 8.33K
- Dr. Christopher Capelli, M.D.
- Independent Director
- 125.31K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data